Evidence-based innovative treatment
targeting the cause of neurogenic dysphagia.
Location: United States, New Hampshire, Manchester
Employees: 11-50
Phone: 820 4525
Total raised: $71.39M
Founded date: 1994
Investors 3
| Date | Name | Website |
| - | Innvotec | innvotec.c... |
| - | Ranworth C... | ranworthca... |
| - | Inventages | inventages... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 04.03.2024 | Series D | $42M | - |
| 22.05.2013 | Series B | $17M | - |
| 04.10.2011 | Series B | $9.31M | - |
| 11.09.2010 | - | $3.08M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 10.03.2024 | Phagenesis: A Game-Changer in Swallowing Dysfunction Treatme... | Manchester-based company Phagenesis has secured a hefty $42M in Series D financing to further develo... | parsers.vc... |
| 04.03.2024 | EQT Life Sciences and Sectoral lead $42M investment in medte... | Medtech company Phagenesis, which has developed a revolutionary neurostimulation system to treat swa... | tech.eu/20... |
| 04.03.2024 | Phagenesis Closes $42M Series D Financing | Phagenesis, a Manchester, UK-based company which has developed a neurostimulation system to treat sw... | finsmes.co... |
| 04.03.2024 | Phagenesis, a medical device company specializing in the tre... | MANCHESTER, England, March 4, 2024 /PRNewswire/ -- Phagenesis, a pioneering UK company which has dev... | en.prnasia... |
| 04.03.2024 | Exclusive: Medtech Phagenesis nets $42M Series D | Swallowing dysfunction treatment developer Phagenesis gobbled up $42 million in Series D financing, ... | axios.com/... |
| 22.05.2013 | Phagenesis Expands Series B to $17M | MANCHESTER, ENGLAND, Leading company in the treatment of dysphagia, has expanded its Series B fina... | vcnewsdail... |
| 22.05.2013 | Phagenesis Extends Series B Financing to $17M | Phagenesis, a Manchester, UK-based developer of solutions for the treatment of dysphagia, has expand... | finsmes.co... |
| 22.05.2012 | Phagenesis Awarded £1M from the Wellcome Trust | Phagenesis Ltd, a Manchester Science Park-based provider of technology designed to treat patients wh... | finsmes.co... |
| 04.10.2011 | Phagenesis Closes Euro 7M Series B | Investment in leader in the treatment of dysphagia led by Inventages, one of the world's largest l... | vcnewsdail... |
| 04.10.2011 | Phagenesis Closes €7M Series B Funding Round | Phagenesis Ltd, a Manchester, UK-based company that is developing a treatment for acute and chronic ... | finsmes.co... |
Show more